Frequency of Care for Peripherally Inserted Central Vascular Access In the Prevention of Marsi
- Sponsor
- Institut Català d'Oncologia
- Study ID
- NCT07697170
- Status
- Enrolling By Invitation
Conditions
- Cancer Pancreas
- Colon Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Weekly dressing for peripherally inserted central catheters — PROCEDUREdressing changes for peripherally inserted central catheters every week
- 15 days dressing change for peripherally inserted central catheters — PROCEDUREEach 15 days dressing change for peripherally inserted central catheters
- peripherally inserted central catheters — PROCEDUREperipherally inserted central catheters
Study Details
This randomized controlled clinical trial evaluates the safety equivalence between weekly and biweekly dressing changes for peripherally inserted central catheters (PICC) in oncology patients receiving outpatient chemotherapy. The study will assess vascular access functionality, skin integrity including Medical Adhesive-Related Skin Injury (MARSI), and the incidence of catheter-related complications. A total of 150 adult patients with colon or pancreas cancer receiving chemotherapy and requiring PICC insertion will be randomized into two groups: weekly dressing changes (control group) or biweekly dressing changes every 14 days (intervention group). Participants will be followed during chemotherapy treatment for a minimum of six cycles and up to twelve sessions. Outcomes include catheter-related complications, patient satisfaction with vascular access care, and quality of life measured using the EORTC QLQ-C30 questionnaire (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire).
Key Dates
- First listed
- Jul 13, 2026
- Start date
- Jun 10, 2026
- Status verified
- Jul 2026
- Primary completion
- Oct 1, 2027
- Completion
- Feb 1, 2028
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Placebo Comparator: Arm 1: Weekly Dressing ChangeParticipants will receive standard Inserted Central Catheters (PICC) care consisting of weekly dressing replacement according to the institutional vascular access care protocol using aseptic technique. Intervention Type: Procedure Intervention Name: Weekly PICC Dressing Change
- Active Comparator: Arm 2. Biweekly Inserted Central Catheters (PICC) dressing changeBiweekly Inserted Central Catheters (PICC) dressing change
Primary Outcome Measure
Number of Participants with Medical Adhesive-Related Skin Injury (MARSI) [ Time Frame: - Control group: Baseline, every 1 week until 24 weeks or end of systemic treatment, whichever occurs first. - Intervention group: baseline, every 2 week until 24 weeks or end of systemic treatment, whichever occurs first. ]
Find similar trials
Related Studies
- Collection of Blood From Patients With CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer StudiesRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado